Correction to: Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations
Barbara Schwartzberg, John Lewin, Osama Abdelatif, Jacqueline Bernard, Hanadi Bu-Ali, Simon Cawthorn, Margaret Chen-Seetoo, Sheldon Feldman, Sasirekha Govindarajulu, Lyn Jones, Arne Juette, Sanjay Kavia, Robert Maganini, Simon Pain, Mike Shere, Craig Shriver, Simon Smith, Alexandra Valencia, Eric Whitacre, Roger Whitney, Barbara Schwartzberg, John Lewin, Osama Abdelatif, Jacqueline Bernard, Hanadi Bu-Ali, Simon Cawthorn, Margaret Chen-Seetoo, Sheldon Feldman, Sasirekha Govindarajulu, Lyn Jones, Arne Juette, Sanjay Kavia, Robert Maganini, Simon Pain, Mike Shere, Craig Shriver, Simon Smith, Alexandra Valencia, Eric Whitacre, Roger Whitney
Abstract
The article "Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations", written by Barbara Schwartzberg et al., was originally published electronically on the publisher's internet portal (currently SpringerLink) on July 9, 2018, without open access.
Source: PubMed